EUVIMEDEUVIMED entdecken
Open Access

Loss of Type 2 Bone Morphogenetic Protein Receptor Activates NOD‐Like Receptor Family Protein 3/Gasdermin E‐Mediated Pyroptosis in Pulmonary Arterial Hypertension

Xiao-Ting Tian, Zhou-Yang-Fan Peng, Yu-Si Wu, Yuan-Yuan Cao, Xue-Chun Li, Ying Li, Si-Yuan Tang, Alex F Chen iD, Xiao-Hui Li iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.034726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Xiao-Ting Tian und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Vascular Disease and Translational Medicine, The Third Xiangya Hospital Central South University Changsha Hunan China. Hauptthemen laut MEDLINE: Pyroptosis, NLR Family, Pyrin Domain-Containing 3 Protein, Bone Morphogenetic Protein Receptors, Type II, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Pulmonary arterial hypertension (PAH) is an incurable disease initiated by endothelial dysfunction, secondary to vascular inflammation and occlusive pulmonary arterial vascular remodeling, resulting in elevated pulmonary arterial pressure and right heart failure. Previous research has reported that dysfunction of type 2 bone morphogenetic protein receptor (BMPR2) signaling pathway in endothelium is inclined to prompt inflammation in PAH models, but the underlying mechanism of BMPR2 deficiency‐mediated inflammation needs further investigation. This study was designed to investigate whether BMPR2 deficiency contributes to pulmonary arterial hypertension via the NLRP3 (NOD‐like receptor family protein 3)/GSDME (gasdermin E)‐mediated pyroptosis pathway. METHODS AND RESULTS NLRP3 knockout or short hairpin RNA interference of GSDME was performed in PAH animal models to investigate its effect on PAH progression. In addition, the effects of BMPR2 deficiency and restoration of BMPR2 by BMP9 (bone morphogenetic protein 9) or FK506 on pyroptosis were explored both in animal and cell models. Knockout of NLRP3 or short hairpin RNA interference of GSDME in animal models can alleviate the development of pyroptosis, accompanied with improved endothelial integrity, vascular remodeling, and right ventricular systolic pressure. Blocking BMPR2 is sufficient to induce NLRP3 upregulation and release of inflammatory factor IL‐1β (interleukin‐1β) in pulmonary arterial endothelial cells. Moreover, BMPR2 deficiency can induce GSDME‐mediated pyroptosis through NLRP3 activation in 2 animal models, whereas activation of BMPR2 signaling by FK506 or BMP9 can reverse these phenotypes. CONCLUSIONS These findings provide evidence that loss of BMPR2 signaling promotes endothelial cell pyroptosis by enhancing NLRP3/GSDME signaling in PAH. Our findings may provide new insights to explore the inflammatory mechanism of PAH treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisNLR Family, Pyrin Domain-Containing 3 ProteinBone Morphogenetic Protein Receptors, Type IIPulmonary Arterial HypertensionPulmonary ArteryHypertension, PulmonaryAnimalsDisease Models, AnimalSignal TransductionMice, KnockoutMice, Inbred C57BLMaleHumansMiceArterial Pressure

Stichwörter der Autor:innen

BMPR2GSDMENLRP3pulmonary arterial hypertensionpyroptosis

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinBone Morphogenetic Protein Receptors, Type IINlrp3 protein, mouseBmpr2 protein, mouse

Autor:innen und Institutionen

  • The Center for Vascular Disease and Translational Medicine, The Third Xiangya Hospital Central South University Changsha Hunan China.
  • Department of Pharmacology, Xiangya School of Pharmaceutical Science Central South University Changsha China.
  • Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples Changsha China.
  • Department of Health Management Center, The Third Xiangya Hospital Central South University Changsha China.
  • Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan, School of Medicine Hunan Normal University Changsha China.
  • Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital Shanghai Jiao Tong University School of Medicine Shanghai China.

ORCID-Profile: Alex F Chen, Xiao-Hui Li

Zitieren

APA

Tian, X. T., Peng, Z. Y., Wu, Y. S., Cao, Y. Y., Li, X. C., Li, Y., Tang, S. Y., Chen, A. F., & Li, X. H. (2025). Loss of Type 2 Bone Morphogenetic Protein Receptor Activates NOD‐Like Receptor Family Protein 3/Gasdermin E‐Mediated Pyroptosis in Pulmonary Arterial Hypertension. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.034726

Vancouver

Tian XT, Peng ZY, Wu YS, Cao YY, Li XC, Li Y, et al. Loss of Type 2 Bone Morphogenetic Protein Receptor Activates NOD‐Like Receptor Family Protein 3/Gasdermin E‐Mediated Pyroptosis in Pulmonary Arterial Hypertension. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.034726

BibTeX
@article{Tian2025,
  author = {Tian, Xiao-Ting and Peng, Zhou-Yang-Fan and Wu, Yu-Si and Cao, Yuan-Yuan and Li, Xue-Chun and Li, Ying and Tang, Si-Yuan and Chen, Alex F and Li, Xiao-Hui},
  title = {Loss of Type 2 Bone Morphogenetic Protein Receptor Activates NOD‐Like Receptor Family Protein 3/Gasdermin E‐Mediated Pyroptosis in Pulmonary Arterial Hypertension},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.034726}
}
Kostenlos starten →